20.46  0.41 (2.04%)		07-18 16:00
Open: 20.24 High: 21.03 Volume: 76,326		Pre. Close: 20.05 Low: 20.1 Market Cap: 221(M)

Short term
Mid term
Targets	6-month :	24.82	1-year :	28.99
Resists	First :	21.25	Second :	24.82
Pivot price	19.84
Supports	First :	19.55	Second :	18.5
MAs	MA(5) :	20.19	MA(20) :	19.71
	MA(100) :	18.52	MA(250) :	18.09
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	54.1	D(3) :	52.3
RSI	RSI(14): 55.5
52-week	High :	22.5	Low :	14.14

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MDWD ] has closed below upper band by 24.7%. Bollinger Bands are 27.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	21.05 - 21.13	21.13 - 21.22
Low:	19.88 - 19.97	19.97 - 20.07
Close:	20.3 - 20.44	20.44 - 20.6

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Mon, 30 Jun 2025
MediWound Ltd.(NasdaqGM: MDWD) added to Russell Small Cap Comp Value Index - MarketScreener

Wed, 21 May 2025
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Fri, 21 Mar 2025
MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Lo - GuruFocus

Thu, 20 Mar 2025
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue G - GuruFocus

Wed, 19 Mar 2025
MediWound Reports 2024 Financials and Strategic Advances - TipRanks

Wed, 19 Mar 2025
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	11 (M)
Shares Float	8 (M)
Held by Insiders	17.9 (%)
Held by Institutions	43.5 (%)
Shares Short	917 (K)
Shares Short P.Month	962 (K)

EPS	-2.05
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2.9
Profit Margin	-110.5 %
Operating Margin	-132.2 %
Return on Assets (ttm)	-19.9 %
Return on Equity (ttm)	-78 %
Qtrly Rev. Growth	-20.3 %
Gross Profit (p.s.)	0.25
Sales Per Share	1.77
EBITDA (p.s.)	-1.86
Qtrly Earnings Growth	0 %
Operating Cash Flow	-13 (M)
Levered Free Cash Flow	-15 (M)

PE Ratio	-9.99
PEG Ratio	0
Price to Book value	7.05
Price to Sales	11.51
Price to Cash Flow	-16.85

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.